pillbase.ru

Nucala

Active substance: mepolizumab

Mepolizumab

Centralised EU authorisationActive

Marketing holder: GlaxoSmithKline Trading Services Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Нукала
    раствор для подкожного введения, 100 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-№(001771)-(РГ-RU)
    АО "ГлаксоСмитКляйн Трейдинг"
  • Нукала
    лиофилизат для приготовления раствора для подкожного введения, 100 мг, 100 мг (original in Russian, GRLS)
    ЛП-№(012190)-(РГ-RU)
    АО "ГлаксоСмитКляйн Трейдинг"
  • Нукала
    лиофилизат для приготовления раствора для подкожного введения, 100 мг, 100 мг (original in Russian, GRLS)
    ЛП-004794
    АО "ГлаксоСмитКляйн Трейдинг"
US 3
  • Nucala
    INJECTION, SOLUTION · MEPOLIZUMAB 100 mg/mL
    0173-0892
    GlaxoSmithKline LLC
  • Nucala
    INJECTION, SOLUTION · MEPOLIZUMAB 40 mg/.4mL
    0173-0904
    GlaxoSmithKline LLC
  • Nucala
    INJECTION, POWDER, FOR SOLUTION · MEPOLIZUMAB 100 mg/mL
    0173-0881
    GlaxoSmithKline LLC
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-430e-7482-95a5-c73f4e6c2610,01a120c3-ca43-78f4-9d54-1174fcc90d38,01a120c5-c55a-7ab0-a658-7ea8f7cf5998;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5e93-7f58-bb4b-dac1adb409e4,01a1208c-5ea3-75eb-afad-6fe8cad3955f,01a12091-9793-7eb0-b5ae-fd0c1778dad4;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003860
Registration status
Active
ATC code
R03DX09
Sources
  • product · EMA · EMEA/H/C/003860 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003860 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003860 · Verified 2026-10-09